NOVOMED, OOO, Tula Oblast

Economic indicators

Net profit (RAS) of NOVOMED, OOO dropped in 2022 by 45.85% to 1.14 million RUB from 2.10 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 35.07% to 9.95 million RUB from 15.33 million RUB in 2021.

Net profit (RAS) of NOVOMED, OOO dropped in 2021 by 22.14% to 2.10 million RUB from 2.69 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period 1.52 times to 15.33 million RUB from 10.10 million RUB over 2020.

Net profit (RAS) of NOVOMED, OOO grew over 2020 15.12 times to 2.69 million RUB from 178.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period 2.90 times to 10.10 million RUB from 3.49 million RUB over 2019; cost of goods sold grew 2.19 times to 7.18 million RUB from 3.27 million RUB; sales profit went up 13.69 times to 2.92 million RUB from 213.00 thousand RUB.

Net profit (RAS) of NOVOMED, OOO made up 225.00 thousand RUB over 2018 compared to net loss of 1.82 million RUB over 2017, the company informed.

Revenue increased in the accounting period 9.80 times to 4.42 million RUB from 451.00 thousand RUB over 2017; cost of goods sold grew 1.83 times to 4.15 million RUB from 2.27 million RUB; sales profit made up 269.00 thousand RUB compared to sales loss of 1.82 million RUB.

Companies in the region

• PROGRESS - M
• AGAT
• FORMULA ZHIZNI
• SNABAVTO-T
• AZS